Formoterol dry-powder inhalation - Sofotec

Drug Profile

Formoterol dry-powder inhalation - Sofotec

Alternative Names: Formoterol 12µg Novolizer; Formoterol 6µg Novolizer; Formoterol fumarate dihydrate powder inhaler - Sofotec

Latest Information Update: 06 Mar 2014

Price : $50

At a glance

  • Originator Sofotec
  • Class Antiasthmatics; Bronchodilators; Ethanolamines; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 06 Mar 2014 Discontinued - Clinical-Phase-Unknown for Asthma in Germany (Inhalation)
  • 29 Sep 2004 Clinical trials in Asthma in Germany (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top